New Study Shows Longhorn Vaccines and Diagnostics’ PrimeStore Molecular Transport Medium Improves Tuberculosis Testing in Children

Previous
Previous

Longhorn Vaccines and Diagnostics to Present Durability Data of Peptide-Based Vaccine LHNVD-201 for Covid-19 and Influenza Co-Infections at 17th Vaccine Congress

Next
Next

9 BioHealth Capital Region Companies That Are Developing Innovative Vaccines and Therapeutics to Combat Global Health Threats